In this study, we evaluated the potential regulation of FTO and NAMPT as two novel candidates potentially involved in the pathophysiology of obesity and metabolic sequelae by metabolic regulators at the level of adipocytes. The gene discussed is NAMPT; the disease is obesity disorder.